NovaBay Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of NBY for the last quarter is 2.63 M USD, and it's 29.41% lower compared to the previous quarter. The net income of Q1 24 is -3.09 M USD.